相关实验视频

Updated: Jul 11, 2025

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

17.1K

免疫疗法和肺细胞病理学:概述和可能性

Maria D Lozano1,2,3, Allan Argueta1, Carlos de Andrea1,2,3,4

  • 1Department of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.

Cytopathology : official journal of the British Society for Clinical Cytology
|November 16, 2023
PubMed

Insights

免疫疗法在癌症治疗方面表现有前途,PD-L1测试对评估至关重要. 这篇评论探讨了细胞病理学.

科学领域:

  • 瘤学和病理学
  • 癌症免疫治疗研究 癌症免疫治疗研究

背景情况:

  • 免疫疗法已经成为一种重要的癌症治疗方式.
  • 免疫组织化学 (IHC) 是编程死亡连接体1 (PD-L1) 和编程死亡1 (PD1) 评估的标准.
  • PD-L1测定适用于甲固定嵌 (FFPE) 组织和细胞样本,但涂抹的验证正在进行中.

研究的目的:

  • 通过免疫细胞化学 (ICC) 审查细胞病理学在分析PD-L1表达中的作用.
  • 在癌症免疫治疗的背景下探索细胞病理学的未来方向.
  • 突出在细胞学样本中对PD-L1解释的先进成像和算法的潜力.

主要方法:

  • 在细胞学样本中对PD-L1测试现有文献的审查.
  • 讨论用于PD-L1评估的免疫组织化学 (IHC) 和免疫细胞化学 (ICC) 技术.
  • 在最小侵入性细胞学样本上进行多重免疫光 (mIF) 分析的探索.

主要成果:

  • 虽然IHC已经确立,但在细胞学涂抹上应用PD-L1测定需要进一步验证.
  • 数字成像和算法为在细胞学样本中改进PD-L1的解释提供了潜力.
  • 在细胞学样本上的多重复合免疫光 (mIF) 是研究非小细胞肺癌 (NSCLC) 瘤免疫微环境的一个有希望的方法.

结论:

  • 细胞病理学在评估免疫疗法的生物标志物方面发挥着越来越重要的作用.
  • 需要进一步的研究和验证,以优化对细胞学样本的PD-L1测试.
  • 像mIF这样的先进技术对NSCLC的综合免疫分析具有前途.
抽象的

No abstract available in PubMed .

关键词:
生物标志物 生物标志物细胞块的细胞块.细胞科学细胞学数字病理学数字病理学精细的针吸入精细的针.肺 肺 肺 肺 肺 肺 肺 肺 肺非小细胞肺癌 (NSCLC) 是一种非小细胞肺癌.编程死亡连接体1 (PD-L1) 编程死亡连接体涂抹涂抹的涂抹是什么意思

更多相关视频

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

13.8K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376